Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-31 3:17 pm Purchase |
2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
BLACKROCK INC BLK |
3,753,075 18.000% |
281,660 (+8.11%) |
Filing History |
| 2022-02-14 6:31 pm Unchanged |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Armistice Capital, LLC | 1,056,000 5.100% |
0 (Unchanged) |
Filing History |
| 2022-02-14 6:18 pm Purchase |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
FIRST MANHATTAN CO | 1,108,836 5.460% |
343,268 (+44.84%) |
Filing History |
| 2022-02-14 5:14 pm Sale |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Armistice Capital, LLC | 1,056,000 5.100% |
-300,000 (-22.12%) |
Filing History |
| 2022-02-11 1:08 pm Sale |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
FARALLON CAPITAL MANAGEMENT LLC | 1,573,829 7.700% |
-201,171 (-11.33%) |
Filing History |
| 2022-02-11 11:11 am Sale |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
STATE STREET CORP STT |
1,127,069 5.550% |
-46,171 (-3.94%) |
Filing History |
| 2022-02-10 6:09 pm Sale |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Renaissance Technologies LLC | 714,400 3.480% |
-319,500 (-30.90%) |
Filing History |
| 2022-02-10 08:11 am Sale |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
The Vanguard Group | 1,625,909 8.000% |
-174,670 (-9.70%) |
Filing History |
| 2022-02-04 4:08 pm Sale |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Dworsky Alan J | 114,496 1.000% |
-1,092,915 (-90.52%) |
Filing History |
| 2022-01-28 1:54 pm Purchase |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
BLACKROCK INC BLK |
3,471,415 17.100% |
65,415 (+1.92%) |
Filing History |
| 2021-12-17 4:31 pm Purchase |
2021-12-15 | 13D | Enanta Pharmaceuticals, Inc. ENTA |
Jay R. Luly, Ph.D. | 1,366,318 6.500% |
176,529 (+14.84%) |
Filing History |
| 2021-02-16 5:05 pm Purchase |
2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Armistice Capital, LLC | 1,356,000 6.700% |
1,356,000 (New Position) |
Filing History |
| 2021-02-16 12:23 pm Sale |
2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
PRICE T ROWE ASSOCIATES INC | 961,445 4.700% |
-434,890 (-31.15%) |
Filing History |
| 2021-02-12 6:42 pm Purchase |
2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 8.800% |
25,000 (+1.43%) |
Filing History |
| 2021-02-10 12:19 pm Purchase |
2020-09-18 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Renaissance Technologies LLC | 1,033,900 5.130% |
1,033,900 (New Position) |
Filing History |
| 2021-02-10 10:52 am Purchase |
2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
The Vanguard Group | 1,800,579 8.970% |
102,850 (+6.06%) |
Filing History |
| 2021-02-09 12:33 pm Purchase |
2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
STATE STREET CORP STT |
1,173,240 5.840% |
1,173,240 (New Position) |
Filing History |
| 2021-01-28 08:40 am Sale |
2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Dworsky Alan J | 1,207,411 6.000% |
-2,362 (-0.20%) |
Filing History |
| 2021-01-25 4:49 pm Purchase |
2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
BLACKROCK INC BLK |
3,406,000 17.000% |
582,432 (+20.63%) |
Filing History |